Trade Summary

5 days ago, Botwood Nicholas A.J., serving as Head of R&D, CMO at Syndax Pharmaceuticals Inc (SNDX), sold 65,515 shares at $18.07 per share, for a total transaction value of $1,183,642.90. Following this transaction, Botwood Nicholas A.J. now holds 60,885 shares of SNDX.

This sale represents a 51.83% decrease in Botwood Nicholas A.J.'s stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, June 11, 2026 and publicly disclosed via SEC Form 4 filing on Friday, June 12, 2026 at 5:09 PM ET, 1 day after the trade was made.

Syndax Pharmaceuticals Inc operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.